The FDA has delayed tolebrutinib’s review date again, as Sanofi also posted a Phase III failure for the MS candidate.

The existing clinical data supporting safety and efficacy of CardiAMP Cell Therapy for HFrEF is subject to ongoing regulatory discussions in Japan and the United States. The compilation includes data ...

With just hours left to choose a plan for coverage that takes effect Jan. 1, Arkansans shopping for coverage through healthcare.gov are facing a double whammy of higher premiums and lower subsidies ...

Officials at Get Covered Illinois, the new state-run marketplace for insurance sold under the Affordable Care Act, announced ...

SPRINGFIELD – Illinois residents who buy health insurance on the state-run marketplace now have a little more time to sign up for coverage for the upcoming year.

Republican leaders on the committee charged with oversight of Education Freedom Accounts (EFAs) that failed to meet for a ...